Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Invested Capital: 2018-2021

Historic Invested Capital for Black Diamond Therapeutics (BDTX) over the last 3 years, with Sep 2021 value amounting to $218.9 million.

  • Black Diamond Therapeutics' Invested Capital fell 33.15% to $218.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $218.9 million, marking a year-over-year decrease of 33.15%. This contributed to the annual value of $307.8 million for FY2020, which is 752.62% up from last year.
  • According to the latest figures from Q3 2021, Black Diamond Therapeutics' Invested Capital is $218.9 million, which was down 12.78% from $251.0 million recorded in Q2 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Invested Capital peaked at $356.2 million during Q1 2020, and registered a low of -$47.2 million during Q4 2019.
  • For the 3-year period, Black Diamond Therapeutics' Invested Capital averaged around $177.1 million, with its median value being $251.0 million (2021).
  • Per our database at Business Quant, Black Diamond Therapeutics' Invested Capital tumbled by 240.85% in 2019 and then spiked by 1,947.76% in 2020.
  • Black Diamond Therapeutics' Invested Capital (Quarterly) stood at -$13.8 million in 2018, then crashed by 240.85% to -$47.2 million in 2019, then skyrocketed by 752.62% to $307.8 million in 2020, then plummeted by 33.15% to $218.9 million in 2021.
  • Its last three reported values are $218.9 million in Q3 2021, $251.0 million for Q2 2021, and $280.8 million during Q1 2021.